Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Center Hospital East
Lund University Hospital
Hoffmann-La Roche
University of Alabama at Birmingham
Revolution Medicines, Inc.
Celgene
Boston Scientific Corporation
University of Alberta
Imunon
NanOlogy, LLC
Duke University
University Medical Center Groningen
Catalysis SL
Catalysis SL
Qure Healthcare, LLC
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Celgene
Catalysis SL
Zhejiang University
Celgene
Institut Bergonié
Nextrast, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhejiang University
Isofol Medical AB
Lund University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Portsmouth Hospitals NHS Trust
South Tyneside and Sunderland NHS Foundation Trust
Novartis
Hôpital Edouard Herriot
Yale University
Metabiomics Corp
Exact Sciences Corporation
Exact Sciences Corporation
Eastern Hepatobiliary Surgery Hospital
Exact Sciences Corporation
University Hospital, Bordeaux
Exact Sciences Corporation
Exact Sciences Corporation
Cook Group Incorporated
University Hospital, Bordeaux
Radboud University Medical Center
AVEO Pharmaceuticals, Inc.